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Abstract  
Introduction: Contrary to some earlier teachings that central nervous system (CNS) tumours are uncommon in black children, these neoplasms 
are the fourth most common paediatric tumours in Ibadan. Our centre is the major referral centre for CNS tumours in Nigeria. The last major study 
of paediatric CNS neoplasms from Ibadan was in 1985. An update of the data on paediatric CNS neoplasms at our centre is presented. 
Methods: A retrospective review of all histologically diagnosed CNS tumours in children (0-14 years) from January 2001 to December 2010 from 
the database of the Department of Pathology, University College Hospital, Ibadan, Nigeria was done. The cases were classified using the 2007 
WHO Classification of Tumours of the Central Nervous System and were also based on their supratentorial and infratentorial locations. 
Results: Seventy-seven tumours, 44 in males, were included in the study. Astrocytic tumour comprised 20 cases, embryonal tumours 15, 
ependymal tumours 15, germ cell tumours 6, sellar tumours (all craniopharyngiomas) 9 and other histological types- 12 cases. Thirty-seven were 
WHO Grade 1, eleven Grade 2, ten Grade 3 and nineteen Grade 4 neoplasms. Thirty-six cases were supratentorial and thirty-eight were 
infratentorial in location. The most common tumours in this series were pilocytic astrocytomas, medulloblastomas, craniopharyngiomas and 
ependymomas in that order. Conclusion: Childhood CNS tumours are being increasingly diagnosed in our centre. This is largely explained by the 
recent expansion of the available neurosurgical services. 
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Introduction 
 
Only three decades ago, it was widely believed that the incidence of 
gliomas was relatively low in black children, when compared with 
Caucasian children [1, 2]. Although central nervous system(CNS) 
neoplasms are the second most common paediatric tumours in 
Caucasians series [3-5], they only rank as the fourth most common 
paediatric tumour in the past studies in Ibadan, Nigeria [1, 2]. 
Furthermore, a recent review of paediatric neoplasms from Ibadan 
documented a six-fold increase, from 2.2% to 12.9%, in the relative 
frequency of paediatric CNS neoplasms over a period of five 
decades [6]. Another study in 2007 revealed that 37% of all CNS 
neoplasms at our centre occurred in children [7]. It is speculated 
that a similar trend can be inferred for other centres in Nigeria. The 
reason that can be allude for this is the recent modest increase in 
access to high-resolution diagnostic tools such as computed 
tomography (CT) scanning and magnetic resonance imaging (MRI). 
Our nation has also recently begun to witness a progressive 
increase in the critical mass of competent clinical neuroscientists 
including those in neurosurgery, adult and paediatric neurology, 
neuroradiology, neuropathology and neuro-ophthalmology, as well 
as some other ancillary medical staff. The CNS is an extremely 
complex and specialised system known to harbour an array of 
approximately 130 primary neoplasms [8]. The pattern of CNS 
tumours in childhood differs in terms of the histopathologic 
subtypes as well as the anatomical location from those in adults. 
Generally, the main tumour groups in children are astrocytomas 
(38-50%), ependymoma (8-14%), primitive neuroectodermal 
tumours (PNET), including medulloblastoma(16-25%), and other 
gliomas (4-16%) [9]. The distinction between benign and malignant 
neoplasms is blurred in the brain; in that all CNS neoplasms may 
eventually be attended by fatal raised intracranial pressure (ICP), 
irrespective of the degree of histological differentiation. In this 
respect, and especially so in many countries in sub-saharan African , 
many childhood CNS neoplasms often only come to clinical 
awareness after their initial non-specific symptomatology has 
evolved to more terminal ones like those of raised ICP. There is a 
gross lack of data on the demographic patterns of paediatric CNS 
tumours in many developing countries of the world due to non 
availability of reliable data collection, poor infrastructure for cancer 
registries and many other logistic constraints. Since the last major 
study of childhood CNS neoplasm from our centre in 1985, there 
has been no further attempt at a review targeted primarily at 
childhood CNS tumours in Ibadan, Nigeria, the nation's flagship 
centre of clinical and academic neuroscience [10]. The aim of this 
present study is therefore to update the data on childhood CNS 
tumours at our centre, describe the histopathological pattern, and 
determine the anatomical distribution of the tumours. We also made 
an attempt at comparison with the previous two studies from our 





This is a retrospective data base study of childhood tumours of the 
central nervous system (CNS) diagnosed in the Department of 
Pathology, University College Hospital, Ibadan, Nigeria between 
January 2001 and December 2010. All CNS neoplasms in children 
aged 0-14 years were retrieved from the files and records of the 
department including autopsy records and from the records of 
Ibadan Cancer Registry (our department falls under its jurisdiction). 
Also a systematic review of the literature was also performed. Cases 
that were not histopathologically confirmed were excluded from the 
study. The data abstracted from patients records include age 
(stratified into 0-4 years, 5-9 and 10-14), gender, intracranial 
location of the tumour (either supra or infratentorial), and the 
specific histological diagnosis. The cases were classified using the 
2007 WHO Classification of Tumours of the Central Nervous System 
after reconfirmation of the diagnosis [8]. Immunohistochemistry 
was used in the confirmation of some cases where necessary. The 
data obtained was entered into the Statistical Programme for Social 
Sciences, version 20 (SPSS Inc, IL, USA) and subjected to analysis. 
This study was conducted in compliance with the guidelines of the 
Helsinki declaration on biomedical research in human subjects. 
Confidentiality of the identity of the patients and personal health 





Seventy seven tumours were included in the study out of which 44 
(57%) were males with a male to female ratio of 1.3:1. The ages of 
the patients ranged from 29 days of life to 14 years with a mean of 
7.2 years and a median of 7 years. Thirty-one cases (40.3%) 
occurred in the age bracket 0-4 years, 27 (35.1%) in 5-9 years and 
19 cases (24.7%) in 10-14 years. In all there were 36 cases 
(46.8%) that were WHO Grade 1, 12 cases (15.6%) were Grade 2, 
10 cases (13.0%)- Grade 3, and 19 (24.7%) were Grade 4 
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neoplasms (Table 1). In other words, 37.7% of the childhood 
tumours of the CNS in Ibadan were of the histologically malignant 
variety. Majority, 16 out of 29 (55.1%) of these occurred in the 0-4 
years age group (Table 1). Overall, astrocytic tumours comprised 20 
(25.9%), embryonal tumours 15 (19.5%), ependymal tumours 15 
(19.5%), sellar tumours- all were craniopharyngiomas 9 (11.7%), 
germ cell tumours 6 (7.8%), meningeal tumours 7 (9.0%) and other 
histological types made up the remaining 5 cases. 
  
Astrocytic neoplasms: The 20 cases recorded comprised of 17 
grade one tumours (16 pilocytic astrocytomas and one case of 
subependymal giant cell astrocytoma), a single Grade 2 tumour 
(fibrillary astrocytoma) and two glioblastomas. 
  
Embryonal neoplasms: These comprised 13 medulloblastomas, 
and a case each of ganglioneuroblastoma and ependymoblastoma. 
  
Ependymal tumours: These comprised a single case of 
myxopapillary ependymoma, 10 ependymomas and 4 cases of 
anaplastic ependymoma. Table 2 show details for all the tumours in 
this series. Thirty-eight (50.6%) cases were infratentorial and thirty 
seven (49.4%) were supratentorial in location. There were two 
spinal region neoplasms. Table 3 shows the details of the 





A recent 5-year (2004-2008) review of data from the Ibadan cancer 
registry shows that, overall, CNS tumours accounted for 2.5% of all 
newly diagnosed registered tumours [11]. However, childhood 
tumours were not well segregated from those of adults in the 
publication. This lack of segregation is what is commonly observed 
in studies on CNS tumours from developing countries [7,12]. In 
many developing countries, including Nigeria, there are significant 
logistic constraints to a complete hospital data collection and 
population based studies are virtually impossible to carry out. 
Hence, most times, hospital based studies are the only source of 
useful data available to describe the pattern of paediatric CNS 
tumours. These, in spite of their known unreliability are then 
sometimes extrapolated for the population [10,12] . This current 
study is the second attempt at detailed documentation of childhood 
CNS tumours from our centre. The first attempt covered a period of 
22 years (1960-1982) [10] and was a report dating back 3 decades. 
A second study that covered an 11 year period was an overview of 
CNS tumours in adults and children with some separation in both 
categories [12]. Table 4 shows a comparison of these two earlier 
studies with the current one. Consistently, astrocytic tumours have 
remained the commonest primary CNS neoplasms in children at our 
hospital though with a downward trend in the percentage from 39% 
to 25.9% in the current study [10,12]. A distinctive finding in the 
current study is the almost complete absence of secondary tumours. 
A comparison to the two previous studies from our centre by 
Aghadiuno et al and Olasode et al show a high percentage of 
secondary involvement of the brain by Burkitt's lymphoma [10,12]. 
None was observed in the present study. This trend of sustained 
decreasing incidence of Burkitt´s lymphoma as an entity and with 
its attendant secondary involvement of the CNS has been observed 
in the last two decades [6]. We are of the opinion that the 
significant improvement in the treatment of malaria and some 
measure of improved nutrition in children from our country have led 
to this trend. Furthermore, ependymomas which were of 
insignificant proportion in the previous two studies have emerged to 
become the second commonest tumours after the astrocytic 
tumours. Because of the corresponding relative decline in astrocytic 
neoplasms observed in the present study, it may be that some 
neoplasms recorded as astrocytic tumours in the previous two 
studies might actually have been ependymal neoplasms. 
  
A comparison of the current study with some other studies from 
different parts of the world, (Table 5), shows that generally 
astrocytic tumours are the commonest neoplasms in most regions of 
the world. Though, astrocytic tumours account for 25.9% in our 
series, their frequency is much higher ranging from 30.5% to 47.3% 
in series from Europe, Asia and South America [13-20]. In this study 
ependymoma was the second ranked tumour, accounting for 19.5% 
of cases. This is in contrast to all the other studies we have 
compared with the current study, in which the frequency ranged 
from 4.8% to 10.5% [14,16,17,21]. The retrospective nature of this 
analysis precludes any meaningful speculations to explain this trend. 
Medulloblastomas accounted for 16.8% of cases in our study and 
ranked the third most common tumour. This ranking and 
percentage of its relative frequency is comparable to that of 10 to 
18.4% recorded in studies from Asia and Europe as illustrated 
in Table 5 [13-18]. The exception to this was a study from Pakistan 
where medulloblastoma accounted for 45.6% of cases in that series 
[21]. 
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Generally boys are usually more affected than girls with regards to 
paediatric CNS tumour. The ratio of 1.3:1 is similar to studies from 
Germany, Iran and Japan [14,17,18]. A higher male:female ratio 
was recorded in studies from China and India [15,16]. Furthermore 
a 2.5:1 male preponderant ratio was recorded in the Pakistani 
study, though gender bias favouring boys having easy accesses to 
health care as a socio-cultural practice might be responsible [12,16]. 
The mean age in this series was 7.3 years. This is somewhat 
relatively lower when compared to studies with similar maximum 
age limit of 14 years inclusion criteria. The studies from Germany, 
Iran, Pakistan had mean age of 10.7, 8.8 and 8.8 years respectively 
[14,17,21]. This difference may not be explainable from the age 
structure in our country where the higher percentage of the 
population is children. Higher mean age is observed in studies with 
higher maximum age limit as inclusion criteria for such studies. In 
the current study, there was almost an equal ratio between supra- 
and infra- tentorial tumours. This is similar to the finding of Kaatsch 
et al and Mehrazin et al from Germany and Iran respectively. 
However, studies from China, South Korea, India and Brazil show a 
preponderance of supratentorial tumours [4,15,16,20,22]. 
Infratentorial tumours were more commonly seen in the studies 





In conclusion astrocytic tumours, ependymomas, medulloblastoma 
and craniopharyngiomas account for about 73% of intracranial 
tumours of children aged 0-14 years of age in this study. Certain 
differences exist in the frequency of occurrence of the tumours 
between this study and others. However, this represents a picture 
of the paediatric brain tumours that came to our attention and that 
were histologically diagnosed in the particularly challenging African 
environment where we practice. 
 
What is known about this topic 
 Central nervous system tumour are rare in Black children; 
 Astrocytic tumours are the commonest CNS tumours in 
children. 
 
What this study adds 
 Increasing diagnostic capabilities at UCH has resulted in 
an increased identification of CNS tumors; 
 This is a good audit of the UCH experience in terms of 
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Table 1: Age group distribution and 
WHO grades of CNS neoplasms of 
children in Ibadan 




I II III IV 
0-4 11 4 6 10 
5-9 15 4 3 5 
10-14 10 4 1 4 
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Table 2: Paediatric CNS neoplasms in Ibadan, Nigeria: gender and 
age group distribution of all tumours in the series 
Morphological subtype 
GENDER AGE GROUPS 









            
Pilocytic astrocytoma 11 5 2.2:1 5 9 2 
Fibrillary astrocytoma 1 -   - 1 - 
Subependymal giant cell 
astrocytoma 
- 1   - - 1 
Glioblastoma 1 1 1:1 1 1 - 
EPENDYMAL TUMOUR             
Myxopapillary 
ependymoma 
- 1   - 1 - 
Ependymoma 7 3 2.3:1 3 3 4 
Anaplastic ependymoma 3 1 3:1 2 2 - 
EMBRYONAL TUMOURS             
Medulloblastoma 5 8 1:1.6 8 3 2 
Ganglioneuroblastoma 1 -   - 1 - 




            
Ganglioglioma - 1   - 1 - 
Dysembryoplastic 
neuroepithelial tumour 
1 -   - - 1 
PINEAL REGION 
TUMOURS 
            
Pinealoblastoma 1 -   - - 1 
TUMOURS OF CRANIAL 
& PARASPINAL 
NERVES 
            
Neurofibroma* - 1   - - 1 
TUMOURS OF THE 
MENINGES 
            
Meningioma 2 3 1:1.5 2 1 2 
Haemangiopericytoma - 1   1 - - 
Lipoblastoma* 1 -   1 - - 
  
GERM CELL TUMOURS 
            
Yolk sac tumour 2 2 1:1 3 - 1 
Immature teratoma - 1   1 - - 
Mixed germ cell tumour 1 -   - 1 - 
TUMOURS OF SELLAR 
REGION 
            
Craniopharyngioma 5 4 1.3:1 3 3 3 
METASTATIC 
TUMOURS 
            
Metastatic neuroblastoma 1 -   - - 1 
TOTAL 44 33   31 27 19 
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Table 3: Paediatric CNS neoplasms in Ibadan, Nigeria: morphologic sub-types in relation to 
anatomical locations 
Morphological sub-types Infratentorial Supratentorial 
Astrocytic tumours 16 4 
Ependymal  tumours 6 9 
Embryonal tumours 14 1 
Neuronal and mixed-glial tumours 1 1 
Pineal region tumours 0 1 
Germ cell tumours 1 5 
Sellar region tumours 0 9 
Meningeal tumours* 0 6 
Nerve sheath tumours* 0 0 
Metastatic tumour 0 1 
TOTAL 38 37 
+One case each in these groups of tumours occurs in the spinal canal. They both were not included 
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Table 4: Paediatric CNS neoplasms in Ibadan, Nigeria: comparison of the two previous studies from Ibadan with the current study 
  
aAghadiuno et al 10    
1960-1982 
89 cases 
bOlasode et al12   
1980-1990 
75 cases 
Current Study  2001-
2010 
77 cases 
ASTROCYTIC TUMOURS 35 (39%) 31 (41.3%) 20 (25.9 %) 
Glioblastoma - 1(1.3%) 2(2.6%) 
EPENDYMAL TUMOURS 4 (4%) - 15(19.5%) 
EMBRYONAL TUMOURS 12 (13%) 8(10.6%) 15(19.5% ) 
Medulloblastoma 12(13%) 8(10.6%) 13(16.8%) 
NEURONAL AND MIXED NEURONAL- GLIAL 
TUMOURS 
- - 2( 2.6%) 
OLIGODENDROGLIAL TUMOURS 2 (2%) 4(5.3%) - 
PINEAL REGION TUMOURS - - 1(1.3%) 
Pinealoblastoma -     
TUMOURS OF CRANIAL & PARASPINAL 
NERVES 
- - 1(1.3%) 
TUMOURS OF THE MENINGES 1(1%) - 7( 9%) 
Meningioma 1 - 5 
GERM CELL TUMOUR 2(2%) 1(1.3%) 6(7.8%) 
Immature teratoma 2 1 1(1.3%) 
TUMOURS OF SELLAR REGION 9(10%) 15 (20%) 9( 11.7%) 
Craniopharyngioma 8(9%) 12(16%) 9 
Pituitary adenoma 1(1%) 3 - 
METASTATIC TUMOURS 21(23%) 13(17.3%) 1(1.3%) 
Neuroblastoma 11(12%) NS 1 
Burkitt's lymphoma 9(10%) 7(9.3%) - 
Myeloid leukaemia 1(1%) NS - 
a,b Vascular tumours as a tumour group were classified in these series. Three cases in each series was not included in the table      NS- Not 



















Table 5:  Paediatric CNS neoplasms in Ibadan, Nigeria: comparison of current study findings with some other series from different parts of the world 
Study Country Total 
Number of 
cases 
Maximum     
Age (years) 













      1 2 3 4         
Peris-Bonet et 
al.13 








NS NS NS NS 
Kaatsch et 
al.14 








PNET (6.4%) 1.2:1 10.7 46.2+ 48.3+ 








Germ cell tumours 
(7.8%) 
1.6:1 NS 61.9 38.1 
Asirvatham et 
al.16 










1.7:1 10.9 53.3 40.6 
Mehrazin et 
al.17 










1.4:1 8.8 51 49 
*Makino et 
al.18 











1.3:1 NS NS NS 
Ahmed  et 
al.21 









2.5:1 8.8 33.3 66.7 










1.3:1 7.2 49.4 50.6 
a Intracranial and intraspinal germ cell tumours were excluded  *These were population based studies      ** included Medulloblastoma which accounted for 45.6% of tumours in the series   NS- Not 
stated   +Spinal Cord and meningeal tumours not included 
